Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Orion OYJ Total Liabilities 2017-2025 | ORINY

Orion OYJ total liabilities from 2017 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Orion OYJ total liabilities for the quarter ending March 31, 2025 were $0.669B, a 18.19% decline year-over-year.
  • Orion OYJ total liabilities for 2024 were $0.675B, a 13.74% increase from 2023.
  • Orion OYJ total liabilities for 2023 were $0.594B, a 5.37% decline from 2022.
  • Orion OYJ total liabilities for 2022 were $0.627B, a 44.86% increase from 2021.
  
Orion OYJ Annual Total Liabilities
(Millions of US $)
2024 $675
2023 $594
2022 $627
2021 $433
2020 $439
2019 $287
2018 $441
2017 $425
2016 $466
Orion OYJ Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $669
2024-12-31 $675
2024-09-30 $751
2024-06-30 $749
2024-03-31 $818
2023-12-31 $594
2023-09-30 $579
2023-06-30 $589
2023-03-31 $606
2022-12-31 $627
2022-09-30 $600
2022-06-30 $554
2022-03-31 $656
2021-12-31 $433
2021-09-30 $369
2021-06-30 $413
2021-03-31 $671
2020-12-31 $439
2020-09-30 $397
2020-06-30 $437
2020-03-31 $442
2019-12-31 $287
2019-09-30 $245
2019-06-30 $291
2019-03-31 $673
2018-12-31 $441
2018-09-30 $409
2018-06-30 $442
2018-03-31 $612
2017-12-31 $425
2017-09-30 $441
2017-06-30 $437
2017-03-31 $472
2016-12-31 $466
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $10.973B $1.669B
Orion Oyj is a pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company's core therapy consists of central nervous system disorders, oncology and respiratory. Its product pipeline includes inhaled Easyhaler(R) pulmonary drugs. Orion Oyj is headquartered in Espoo, Finland.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.319B 28.63
Zoetis (ZTS) United States $66.158B 24.68
Takeda Pharmaceutical (TAK) Japan $45.915B 9.13
Daiichi Sankyo, - (DSNKY) Japan $45.464B 23.30
BeOne Medicines - (ONC) Cayman Islands $32.283B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.049B 0.00
Summit Therapeutics (SMMT) United States $19.458B 0.00
Merck (MKKGY) Germany $16.692B 12.23
Shionogi (SGIOY) Japan $14.207B 0.00
United Therapeutics (UTHR) United States $13.172B 11.65
Neurocrine Biosciences (NBIX) United States $13.065B 44.75
IPSEN (IPSEY) France $10.477B 0.00
Stevanato Group S.p.A (STVN) Italy $7.541B 46.11
Corcept Therapeutics (CORT) United States $7.514B 61.09
Madrigal Pharmaceuticals (MDGL) United States $7.419B 0.00
Grifols, S.A (GRFS) Spain $6.834B 0.00
Ionis Pharmaceuticals (IONS) United States $6.646B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.394B 0.00
Hypermarcas (HYPMY) Brazil $3.056B 20.10
Crinetics Pharmaceuticals (CRNX) United States $2.913B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.565B 8.99
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.498B 13.51
NewAmsterdam Pharma (NAMS) Netherlands $2.492B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.095B 0.00
Ocular Therapeutix (OCUL) United States $1.805B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.802B 0.00
ARS Pharmaceuticals (SPRY) United States $1.760B 0.00
Endo (NDOI) United States $1.606B 0.00
Evotec AG (EVO) Germany $1.513B 0.00
Harrow (HROW) United States $1.317B 0.00
Guardian Pharmacy Services (GRDN) United States $1.283B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.166B 23.32
Enliven Therapeutics (ELVN) United States $1.112B 0.00
Ardelyx (ARDX) United States $1.055B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.048B 0.00
Dyne Therapeutics (DYN) United States $1.025B 0.00
Akebia Therapeutics (AKBA) United States $1.014B 0.00
Collegium Pharmaceutical (COLL) United States $1.003B 5.41
Verve Therapeutics (VERV) United States $0.973B 0.00
ProKidney (PROK) United States $0.922B 0.00
Xeris Biopharma Holdings (XERS) United States $0.799B 0.00
Cronos Group (CRON) Canada $0.775B 0.00
KalVista Pharmaceuticals (KALV) United States $0.769B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.743B 0.00
Zevra Therapeutics (ZVRA) United States $0.660B 0.00
Xencor (XNCR) United States $0.638B 0.00
Relay Therapeutics (RLAY) United States $0.600B 0.00
Elite Pharmaceuticals (ELTP) United States $0.599B 0.00
USANA Health Sciences (USNA) United States $0.565B 12.29
Theravance Biopharma (TBPH) United States $0.563B 0.00
Organogenesis (ORGO) United States $0.554B 0.00
Oruka Therapeutics (ORKA) United States $0.544B 0.00
Bioventus (BVS) United States $0.514B 13.04
Tourmaline Bio (TRML) United States $0.475B 0.00
Siga Technologies (SIGA) United States $0.472B 9.87
Aquestive Therapeutics (AQST) United States $0.417B 0.00
Savara (SVRA) United States $0.391B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.345B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.336B 9.08
Altimmune (ALT) United States $0.331B 0.00
Aldeyra Therapeutics (ALDX) United States $0.323B 0.00
Nektar Therapeutics (NKTR) United States $0.309B 0.00
Heron Therapeutics (HRTX) United States $0.294B 0.00
AleAnna (ANNA) United States $0.292B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.20
Nanobiotix S.A (NBTX) France $0.250B 0.00
OmniAb (OABI) United States $0.238B 0.00
Esperion Therapeutics (ESPR) United States $0.232B 0.00
MediWound (MDWD) Israel $0.221B 0.00
Larimar Therapeutics (LRMR) United States $0.206B 0.00
4D Molecular Therapeutics (FDMT) United States $0.195B 0.00
China SXT Pharmaceuticals (SXTC) China $0.191B 0.00
Galectin Therapeutics (GALT) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.174B 0.00
Profound Medical (PROF) Canada $0.170B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Liminatus Pharma (LIMN) United States $0.141B 0.00
Lexeo Therapeutics (LXEO) United States $0.138B 0.00
Lyell Immunopharma (LYEL) United States $0.137B 0.00
Inhibikase Therapeutics (IKT) United States $0.137B 0.00
Avita Medical (RCEL) United States $0.137B 0.00
Korro Bio (KRRO) United States $0.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.124B 0.00
Protara Therapeutics (TARA) United States $0.119B 0.00
Champions Oncology (CSBR) United States $0.111B 18.20
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
VAXART, INC (VXRT) United States $0.101B 0.00
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
Nutriband (NTRB) United States $0.090B 0.00
Fractyl Health (GUTS) United States $0.088B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Context Therapeutics (CNTX) United States $0.080B 0.00
Dominari Holdings (DOMH) United States $0.079B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.076B 0.00
Metagenomi (MGX) United States $0.074B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Wellgistics Health (WGRX) United States $0.073B 0.00
Rafael Holdings (RFL) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Telomir Pharmaceuticals (TELO) United States $0.068B 0.00
Avalo Therapeutics (AVTX) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Inotiv (NOTV) United States $0.060B 0.00
Klotho Neurosciences (KLTO) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.054B 0.00
Jupiter Neurosciences (JUNS) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 35.78
Gain Therapeutics (GANX) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
PolyPid (PYPD) Israel $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Vivos Therapeutics (VVOS) United States $0.034B 0.00
Karyopharm Therapeutics (KPTI) United States $0.033B 0.00
FibroGen (FGEN) United States $0.031B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Scienture Holdings (SCNX) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
Relmada Therapeutics (RLMD) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.019B 0.00
Incannex Healthcare (IXHL) Australia $0.018B 0.00
VYNE Therapeutics (VYNE) United States $0.018B 0.00
BioVie (BIVI) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.43
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.36
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00